Home › Blood Clots › Florida › Tampa
Blood Clots clinical trials in Tampa, FL
4 studies for Blood Clots are looking for participants at sites in and around Tampa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
RecruitingPhase 3
- Tampa Cardiovascular Interventions and Research, Tampa
Aspiration Thrombectomy Using the Symphony or Prodigy System
RecruitingObservational study
- BayCare Health System - St. Joseph Hospital, Tampa
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
RecruitingPhase 2
- University of South Florida, Tampa
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RecruitingObservational study
- St. Joseph's Hospital Center for Bleeding & Clotting Disorders, Tampa
- University of South Florida - Adult, Tampa
About Blood Clots
Your blood forms clots to stop bleeding. Some people get too many clots or their blood clots abnormally. Learn about the causes and treatments.
More about Blood Clots on MedlinePlus
Blood Clots trials in other cities
- Boston, MA9 studies
- Houston, TX7 studies
- Atlanta, GA7 studies
- Washington, DC5 studies
- Little Rock, AR5 studies
- New York City, NY5 studies
- San Diego, CA4 studies
- Chicago, IL4 studies
- Toledo, OH4 studies
- Orlando, FL4 studies
- Indianapolis, IN4 studies
- Rapid City, SD4 studies
Other studies in Tampa
- Non-Small Cell Lung Cancer53 studies
- Breast Cancer40 studies
- Cancer (all types)38 studies
- Colorectal Cancer36 studies
- Lung Cancer31 studies
- Metastatic Cancer30 studies
- Acute Myeloid Leukemia30 studies
- Pancreatic Cancer26 studies
- Melanoma21 studies
- Ovarian Cancer20 studies
- Alzheimer's Disease20 studies
- Myelodysplastic Syndromes20 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.